Home > Oncology > Mastectomy may raise risk of persistent use of opioids, sedative-hypnotics

Mastectomy may raise risk of persistent use of opioids, sedative-hypnotics


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Conference
2020 San Antonio Breast Cancer Symposium
Reuters Health - 11/12/2020 - Women with breast cancer who undergo mastectomy and reconstructive surgery may be at risk of becoming persistent users of opioids and sedative-hypnotic drugs, according to a new study. "I hope that our study can increase awareness that these are addictive medications, and a brief exposure for surgery-related pain or anxiety can lead to long-term use," Dr. Jacob Cogan said in a news release from the virtual 2020 San Antonio Breast Cancer Symposium where he presented the data. "Both patients and providers should be aware of this issue, and of the risk factors that elevate an individual patient's risk," added Dr. Cogan, a hematology/oncology fellow at NewYork-Presbyterian/Columbia University Irving Medical Center in New York. Using a healthcare claims database, the researchers studied women who underwent mastectomy and reconstruction between 2008 and 2017. They identified prescriptions for opioids and sedative-hypnotics during the p...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on